Qloudlab SA – CONFIDENTIAL – October 2015 1

Arthur QuevalCo-Founder & CEOarthur.queval@qloudlab.com+41 (0) 78 800 86 29

The remote care management platform

Qloudlab SA – CONFIDENTIAL – October 2015 2

P R E S E N TAT I O N

location Innovation Park (“Le Garage” EPFL) founding October 2013status Industrializationemployees 5funding 600 kCHF – seeking 2 mCHFpatent 2 pat. pend.

Qloudlab SA

Qloudlab SA – CONFIDENTIAL – October 2015 3

D I G I T I Z AT I O N O F M E D I C A L C A R E

Disruption and Opportunity on a Massive Scale

1.  Data Driven Disease Management

2.  Remote Healthcare

3.  Democratization of Healthcare (DIY)

4.  Digital Efficiency: Lower cost and fewer errors

Qloudlab is an Enabler of this Disruption

Qloudlab SA – CONFIDENTIAL – October 2015 4

Change in how health care is delivered and managed will create new businesses.

mHealth was estimated to $10.5 bn in 2014 and growing at a CAGR of 33.5%

Qloudlab will focus on a narrow, but large niche.

D I S R U P T I O N O P P O R T U N I T Y

Qloudlab SA – CONFIDENTIAL – October 2015 5Sceptre™, introducing the World’s first modular POCT medical device

O U R S O L U T I O N : R E M O T E D I A G N O S T I C

Qloudlab has developed Sceptre, a remote blood test device

that enables at “home” blood monitoring; cloud linked to

your doctor, empowering him/her to remotely monitor and

improve your care through optimization of your treatment.

Qloudlab SA – CONFIDENTIAL – October 2015 6

Problem Lack of time and data prevents regular monitoring and optimization of Heart Disease patients (too expensive & complex). Most patients seen only 1 or 2 times per year.

Solution Qloudlab’s Sceptre: The easy to use, cloud linked at “home” blood monitoring device that enables doctors to provide better care, more frequently, at lower cost.

W H Y I T I S N E E D E D ?

Qloudlab SA – CONFIDENTIAL – October 2015 7

U S P

EASY & ACCURATE BLOOD SCREENING

—

Providing a full lipid (LDL, HDL, Total Cholesterol, Triglycerides) from a small drop of blood

REMOTE CARE MANAGEMENT

—

Algorithm personalized to each patients in order to improve their treatments

BETTER OUTCOME FOR PATIENTS

—

Benefits for Patients, Hospitals and Pharma.

+ =

Our solution combines state of the art biosensors and a personalized

algorithm to help patients with chronic disease to better manage their

treatment from home. All generated results are instantly synchronized with

their doctors through a secured cloud.

Qloudlab SA – CONFIDENTIAL – October 2015 8blood lipid panel

sceptre device

lipid panel module

sceptre app one for all modules

personalized algorithm based on longitudinal patient data

custom API

TO D AY

Patent pending (filed in June 2014)

Qloudlab SA – CONFIDENTIAL – October 2015 9

!!!

!!!

!!!

blood lipid panel

sceptre device

set of modules

sceptre app one for all modules

custom API

TO M O R R O W

EHR, Doctors, Hospitals, Homecare

Patent pending (filed in June 2014)

personalized algorithm based on longitudinal patient data

Qloudlab SA – CONFIDENTIAL – October 2015 10

-  Role out system in the CHUV (Kick-off: Nov. 2015, First patients tested: June 2016)

-  Integrate device and data into “CHUV Heart Treatment Network” (Including Big Data)

-  Help make the CHUV Switzerland’s premier Heart Disease treatment facility.

-  Test frequency: 1 test /month

-  Number of patients with heart disease treated by CHUV: 5000

-  Better Outcomes at lower total cost

2nd STEP: ROLL-OUT TO OTHER SWISS HOSPITALS

N E A R - T E R M O B J E C T I V E : T H E C H U V

Qloudlab SA – CONFIDENTIAL – October 2015 12

A D R E S S E D M A R K E T ( 1 )

Rest of IVD$50'013 m

81%

Blood glucose$5'020 m

8%

Blood gas & electrolyte$1'078 m

2%

Coagulation$707 m

1%

Cardiac marker$1'760 m

3%

Substance/Drug abuse$564 m

1%

Infectious disease$874 m

1%

Urine strip$364 m

0.5%

Pregnancy$425 m

1%

Fecal$407 m

1%

Cholesterol$666 m

1%

POCT$11'870 m

19%

Total Point-of-Care testing market in 2014

Qloudlab SA – CONFIDENTIAL – October 2015 13

A D R E S S E D M A R K E T ( 2 )

Blood Glucose$2'269 m

46%

Cardiac Markers$755 m

15%

Blood gas and Electrolytes

$293 m6%

Infectious desease$232 m

5%

Coagulation$195 m

4%

Cholesterol Testing$279 m

6%

Substance abuse Testing$252 m

5%

Pregnancy Testing$228 m

5%

Fecal Occult Testing$267 m

5%

Urine Strip$148 m

3%

EU$4.2 bn

2016

2017

European Point-of-Care testing market per test in 2014

Qloudlab SA – CONFIDENTIAL – October 2015 14

A D R E S S E D M A R K E T ( 3 )

France$847 m

17%

Germany$1'174 m

24%

Italy$889 m

18%

Spain$452 m

9%

UK$475 m

9%

Benelux$296 m

6%

Scandinavia$246 m

5%

ROE$591 m

12%

EU$4.2 bn

European Point-of-Care testing market per country in 2014

Qloudlab SA – CONFIDENTIAL – October 2015 16

C O M P E T I T I O N

Company SD Biosensors (South Korea)

PTS Technology (USA)

Acon labs(USA)

Infopia 21(South Korea)

Qloudlab (Switzerland)

Name Lipidocare Cardiochek Mission Lipid Pro Sceptre

Remote monitoring ✕ ✕ ✕ ✕ ✔

Data analytics ✕ ✕ ✕ ✕ ✔

Multitest 2 1 1 2 +12 (modular port)

Device sales price $ 225 $ 645 $ 225 $ 330 $ 350 (w/o smartphone)

Test strip price $ 3.5 $ 10 $ 5 $ 8 $ 5

Qloudlab SA – CONFIDENTIAL – October 2015 17

R O A D M A P 2 0 1 5 - 2 0 1 7

CE mark

ISO 13485

JULY 2016 Product launch

FDA - 510k application

Milestones

Series A – 2 mCHF

tests validated

800 devices in tests

platform industrialized

Series B – 5 mCHF

2015 2016 2017

Seed – 600 kCHF

Qloudlab SA – CONFIDENTIAL – October 2015 18

O U R V I S I O N : T H E “ F U N N E L ”

multiple biosensors

one device

multiple environment

multiple software

Pharma companies

CROs

healthcare providers

multiple tests

cardio-vascular disease

kidney disease

diabetes

!!! !!! !!!

S

…

… …

Qloudlab SA – CONFIDENTIAL – October 2015 19

MOBILE APPLICATION & API —

Qloudlab’s mobile application guide you through the testing procedure and shows you the test results. All generated results can be stored on a secured cloud accessible wherever you are. Compatible with all modules

SCEPTRE & LIPID MODULE —

Sceptre performs the sample analysis and sends the test results back to your mobile device. The Sceptre integrates a modular port so different module can be inserted depending of the tests to be performed.

Additional module(s) (2017)

LIPID PANEL TEST STRIPS —

Full lipid tests strip using a single blood drop (Total Cholesterol, HDL, LDL, Triglycerides)

& &

!!!

!!!

!!!

O U R O F F E R

Qloudlab SA – CONFIDENTIAL – October 2015 20

Arthur Queval CEO, Pres. & co-founderMSc. Eng. EPFL35 patentsExp.: Swatch Group

Dr. Hussein BallanCEO and Founder of Advanced Silicon

Pr. Philippe RenaudProfessor at EPFL Founder of 13 startups in the medical field

Alain Rosier+20 years as CEO of PFM Medical

Maxime Ettori

Simon ChaplinFormer Finance Director, Medtronic

Risto DoncevCSO & Business dev.MSc. EPFL + MBAFormer Bus. dev directorExp.: Sensirion, Baumer

T E A M

CTO & co-founderMSc. Eng. EPFL3 publications in Microfluidics

Pr. Cécile PerraultLecturer at Sheffield University, UK

Andrea CavalliniBiochemistry project managerPhD. Biochemistry, EPFL18 int. publications

Johann SeydouxEmbedded systems project managerBSc. Electrical Eng., HES-SOExp.: Veldana Medical

www.linkedin.com/in/aqueval www.linkedin.com/in/mettori www.linkedin.com/in/ristodoncev

EXECUTIVE TEAM

SCIENTIFIC ADVISORY BOARD BOARD OF DIRECTORS

Qloudlab SA – CONFIDENTIAL – October 2015 21

I N V E S T M E N T P R O P O S A L

2 mCHF

$

In order to reach our objectives for the company, we are currently looking for 2 millions CHF.

To fulfill our potential customers deadlines, the investment due date is January 2016.

14 months

3 goals

We believe our objectives can be achieved by December 2016.

We have defined 3 majors objectives to accomplish in 2016.

Industrialized testing platform (Sceptre, module, lipid panel test strip and iOS App)

CE marked according to directive 98/79EC for IVD medical devices

800 devices in test

Qloudlab SA – CONFIDENTIAL – October 2015 22

blood urine saliva skin Thank you

Sceptre™